Concordia Healthcare to buy Amdipharm Mercury for $3.5 bln

Tue Sep 8, 2015 7:13am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 8 (Reuters) - Concordia Healthcare Corp said it would buy Amdipharm Mercury Ltd from private equity firm Cinven in a deal valued at $3.5 billion.

The deal gives Concordia a portfolio of more than 190 niche pharmaceutical products. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Saumyadeb Chakrabarty)